Legend Biotech
LEGN
LEGN
168 hedge funds and large institutions have $3.18B invested in Legend Biotech in 2022 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 57 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 57
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.06% less ownership
Funds ownership: 20.16% → 19.1% (-1.1%)
Holders
168
Holding in Top 10
4
Calls
$32.8M
Puts
$9.27M
Top Buyers
| 1 | +$128M | |
| 2 | +$51.1M | |
| 3 | +$48.4M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$25.4M |
| 5 |
Barclays
London,
United Kingdom
|
+$8.54M |
Top Sellers
| 1 | -$93.7M | |
| 2 | -$35.6M | |
| 3 | -$34.1M | |
| 4 |
SC
Samlyn Capital
New York
|
-$30.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$23.6M |